Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Capricor Therapeutics, Inc. kasuwar kasuwa

Matsayin kasuwancin jari na Capricor Therapeutics, Inc. a yau da kuma tarihin ƙaddamar da Capricor Therapeutics, Inc. daga farkon kasuwanci a CAPR hannun jari akan musayar jari.
Ƙara zuwa widget din
Ƙara zuwa widget din

Capricor Therapeutics, Inc. girma

Yau kasuwa kasuwa na Capricor Therapeutics, Inc. shine 97 415 464 US dollar.
+2 400 640 $ (+2.53%)
canji na strongn kudi tun jiya

Mene ne tsarin mulkin Capricor Therapeutics, Inc. a yau. Capricor Therapeutics, Inc. ikon mallaka, i.e. yawan shahararrun hannun jari da aka samu ta hanyar farashin hannun jari, ya nuna. Capricor Therapeutics, Inc. aikin kwalliya shine bude bayani. Capricor Therapeutics, Inc. capitalization = 97 415 464 dalar Amurka.

Capricor Therapeutics, Inc. girma na kasuwanci

Yau yaudarar kasuwancin jari Capricor Therapeutics, Inc. ya kai 10 620 US dollar.
-40 341 $ (-79.16%)
canjin karuwar kasuwancin tun jiya

Capricor Therapeutics, Inc. ciniki yana gudana ne a musayar abubuwan musayar jari daban-daban. Shafin yau da kullun na Capricor Therapeutics, Inc. an gabatar da girman ciniki a shafin yanar gizon mu. Capricor Therapeutics, Inc. ciniki a ainihin lokacin da aka gudanar akan musanyar abubuwan musayar jari, gidan yanar gizon mu yana nuna ƙimar ciniki ta yau da kullun ta Capricor Therapeutics, Inc.. Capricor Therapeutics, Inc. karuwanci ya karu idan aka kwatanta da na jiya.

Nuna:
To

Capricor Therapeutics, Inc. kasuwar kasuwa

Capricor Therapeutics, Inc. aikin kwalliya akan zane a shekaru. A cikin sati, Capricor Therapeutics, Inc. karfin kai ya canza daga -1.91%. 0% a kowace shekara - wani canji a cikin kasuwar kasuwancin Capricor Therapeutics, Inc.. Babban ikon kasuwar Capricor Therapeutics, Inc. yanzu ya yi daidai da 97 415 464 dalar Amurka.

Week Watan 3 months Shekara 3 shekaru

Capricor Therapeutics, Inc. tarihin lalata

Kwanan Girma
Babban jari (kasuwannin kasuwa) shine kasuwa na kasuwa na kamfanonin da ke sayarwa akan musayar jari. Mahimmancin kasuwancin yana daidai da farashin hannun jari da yawa ta hanyar yawan kuɗi.
03/05/2023 97 415 464 $
02/05/2023 95 014 824 $
01/05/2023 100 068 808 $
28/04/2023 98 299 912 $
27/04/2023 98 047 216 $
26/04/2023 99 689 752 $
25/04/2023 99 310 712 $

Capricor Therapeutics, Inc. tashar girma

Week Watan 3 months Shekara 3 shekaru

Capricor Therapeutics, Inc. bayanan tarihi na tarihi

Kwanan Volume (24h)
Ƙaramar kasuwancin Capricor Therapeutics, Inc. hannun jari shine yawan yawan ma'amaloli tare da hannun jari na CAPR da aka saya a lokacin da aka zaba.
03/05/2023 10 620 $
02/05/2023 50 961 $
01/05/2023 26 204 $
28/04/2023 6 970 $
27/04/2023 53 629 $
26/04/2023 52 786 $
25/04/2023 67 930 $

Capricor Therapeutics, Inc. ikon mallaka a dalar Amurka yanzu a 03/05/2023. 02/05/2023 Capricor Therapeutics, Inc. ikon mallaka daidai yake da 95 014 824 dalar Amurka. Capricor Therapeutics, Inc. capitalization kasuwa shine $ 100 068 808 a 01/05/2023. Capricor Therapeutics, Inc. karuwancin kasuwa a 28/04/2023 yayi daidai da 98 299 912 dalar Amurka.

Capricor Therapeutics, Inc. aikin mallaka a 27/04/2023 yayi daidai da 98 047 216 dalar Amurka. 26/04/2023 Capricor Therapeutics, Inc. karfaffen kaya ya kai 99 689 752 Dalar Amurka. Capricor Therapeutics, Inc. aikin mallaka a 25/04/2023 yayi daidai da 99 310 712 dalar Amurka.

A capitalization na Capricor Therapeutics, Inc. a yau shi ne 97 415 464 $. Girman kasuwa na Capricor Therapeutics, Inc. ya canza zuwa +2.53% idan aka kwatanta da jiya. Hanyoyin ciniki na CAPR hannun jari na Capricor Therapeutics, Inc. a rana ta ƙarshe ta kasuwanci ya kasance 10 620 $. Ƙarin ciniki na Capricor Therapeutics, Inc. ya canza zuwa -79.161% idan aka kwatanta da ranar ciniki.

Kudin hannun jari Capricor Therapeutics, Inc.

Finance Capricor Therapeutics, Inc.